Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)

The addition of HIPEC to complete or nearly complete primary SCS did not confer a benefit in terms of PFS in patients with platinum-sensitive peritoneal recurrence.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-11-21
DOI
https://doi.org/10.1200/jco.24.00686
Citations
31
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
16.65
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)

Stefano Greggi, Giovanni Aletti, Anna Myriam Perrone, Francesco Fanfani et al.
31 citations
Journal of Clinical Oncology
Ovarian cancer diagnosis and treatment
16.65
article

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)

Stefano Greggi, Giovanni Aletti, Anna Myriam Perrone, Francesco Fanfani, Giovanni Scambia, Vincenzo Dario Mandato, Vito Chiàntera, Vanda Salutari, Giorgio Giorda, Barbara Costantini, Rita Trozzi, Anna Fagotti, Pierandrea De Iaco, Diana Giannarelli
article en
31 citations

Abstract

The addition of HIPEC to complete or nearly complete primary SCS did not confer a benefit in terms of PFS in patients with platinum-sensitive peritoneal recurrence.

Journal of Clinical OncologyVol. 43(7)
Università Cattolica del Sacro Cuore (IT), University of Milan (IT), Agostino Gemelli University Polyclinic (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Saint Camillus International University of Health and Medical Sciences (IT), Azienda USL di Bologna (IT), Centro di Riferimento Oncologico (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), European Institute of Oncology (IT), University of Palermo (IT), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 1%
Ovarian cancer diagnosis and treatment
16.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18) — Stefano Greggi, Giovanni Aletti, et al. · Journal of Clinical Oncology (2024) | TGRS Research Map | TGRS